Multiple Sclerosis Magnetic Resonance Imaging
Item
patients had clinically definite and magnetic resonance image supported ms
boolean
C0026769 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
Relapse Quantity
Item
had at least one relapse in the year before entry into the study
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
EDSS
Item
edss score of 0-5
boolean
C0451246 (UMLS CUI [1])
interferon beta-1b Subcutaneous Dose | Betaseron
Item
treated with subcutaneous 250 μg interferon beta-1b (betaseron, bayer)
boolean
C0244713 (UMLS CUI [1,1])
C1522438 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0284968 (UMLS CUI [2])
Supplement Other
Item
they were taking another supplement
boolean
C0242295 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Progressive multiple sclerosis
Item
had progressive forms of ms
boolean
C0393665 (UMLS CUI [1])
Severe depression
Item
had history of severe depression
boolean
C0588008 (UMLS CUI [1])
Liver Dysfunction | Renal dysfunction
Item
had history of acute liver or renal dysfunction
boolean
C0086565 (UMLS CUI [1])
C3279454 (UMLS CUI [2])
Tobacco Use Disorder | Substance Use Disorders
Item
had history of tobacco, drug or alcohol abuse
boolean
C0040336 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
Intolerance to Fish Oils | Medical contraindication Fish Oils | Fish oils allergy
Item
had intolerance, contraindication or allergy to fish oil
boolean
C1744706 (UMLS CUI [1,1])
C0016157 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0016157 (UMLS CUI [2,2])
C0571871 (UMLS CUI [3])